— Know what they know.
Not Investment Advice

FATE NASDAQ

Fate Therapeutics, Inc.
1W: +10.5% 1M: +53.3% 3M: +43.8% YTD: +87.5% 1Y: +127.2% 3Y: -62.8% 5Y: -97.3%
$2.25
+0.15 (+7.14%)
 
Weekly Expected Move ±23.6%
$1 $1 $2 $2 $3
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 59 · $262.3M mcap · 102M float · 2.16% daily turnover · Short 38% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
32.2 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -135.4%  ·  5Y Avg: -79.7%
Cost Advantage
34
Intangibles
48
Switching Cost
17
Network Effect
39
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. FATE has No discernible competitive edge (32.2/100). The business operates without significant structural advantages. The primary source of advantage is Intangible Assets. Negative ROIC of -135.4% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$4
Low
$4
Avg Target
$4
High
Based on 1 analyst since May 13, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 16Hold: 13Sell: 2Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$4.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-19 Jefferies $145 $4 -141 +111.6% $1.89
2025-03-06 Stifel Nicolaus $5 $3 -2 +188.5% $1.04
2024-11-13 BMO Capital Etzer Darout $6 $5 -1 +48.4% $3.37
2024-08-14 Stifel Nicolaus Benjamin Burnett Initiated $5 +52.9% $3.27
2024-06-16 Piper Sandler Edward Tenthoff $4 $6 +2 +66.4% $3.60
2024-05-16 H.C. Wainwright Debjit Chattopadhyay Initiated $5 +17.9% $4.24
2024-05-10 Piper Sandler Edward Tenthoff $12 $4 -8 +3.1% $3.88
2024-05-10 BMO Capital Etzer Darout $7 $6 -1 +55.2% $3.87
2024-05-10 Canaccord Genuity Bill Maughan Initiated $9 +130.8% $3.90
2023-01-09 Goldman Sachs $10 $4 -6 -9.1% $4.40
2023-01-06 Morgan Stanley Initiated $8 +89.6% $4.22
2023-01-06 Piper Sandler $113 $12 -101 +9.1% $11.00
2023-01-06 BMO Capital Initiated $7 -36.4% $11.00
2023-01-05 Truist Financial Robyn Karnauskas $46 $7 -39 -36.4% $11.00
2022-12-14 Goldman Sachs Andrea Tan Initiated $10 -34.9% $15.37
2022-12-13 Truist Financial Initiated $46 +197.6% $15.46
2021-12-12 Oppenheimer Matthew Biegler Initiated $135 +175.6% $48.98
2021-11-07 Citigroup Yigal Nochomovitz Initiated $87 +43.1% $60.79
2021-11-04 Roth Capital Anthony Butler Initiated $60 -2.3% $61.42
2021-10-24 Jefferies Michael Yee Initiated $145 +149.3% $58.16
2021-08-19 Piper Sandler Edward Tenthoff Initiated $113 +68.6% $67.01

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. FATE receives an overall rating of C. Strongest factors: P/B (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

21 Grade D
Profitability
0
Balance Sheet
83
Earnings Quality
54
Growth
48
Value
41
Momentum
50
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. FATE scores highest in Balance Sheet (83/100) and lowest in Profitability (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-6.68
Distress Zone
Piotroski F-Score
2/9
Beneish M-Score
-4.96
Unlikely Manipulator
Ohlson O-Score
-5.08
Bankruptcy prob: 0.6%
Low Risk
Credit Rating
BB
Score: 42.3/100
Trend: Stable
Earnings Quality
OCF/NI: 0.79x
Accruals: -7.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. FATE scores -6.68, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. FATE scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. FATE's score of -4.96 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. FATE's implied 0.6% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. FATE receives an estimated rating of BB (score: 42.3/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-2.08x
PEG
-0.06x
P/S
41.52x
P/B
1.50x
P/FCF
-1.33x
P/OCF
EV/EBITDA
-0.15x
EV/Revenue
2.89x
EV/EBIT
-0.14x
EV/FCF
-0.17x
Earnings Yield
-90.19%
FCF Yield
-75.05%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. FATE currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.969
EBT / EBIT
×
EBIT Margin
-21.222
EBIT / Rev
×
Asset Turnover
0.017
Rev / Assets
×
Equity Multiplier
1.444
Assets / Equity
=
ROE
-49.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. FATE's ROE of -49.4% is driven by Asset Turnover (0.017), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$2.25
Median 1Y
$1.14
5th Pctile
$0.26
95th Pctile
$4.95
Ann. Volatility
92.0%
Analyst Target
$4.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Bahram Valamehr, Ph.D.,
MBA President, Chief Executive Officer and Director
$600,000 $— $2,248,568
Cindy R. Tahl,
J.D. Chief Legal & Compliance Officer and Corporate Secretary
$520,000 $92,400 $1,111,996
Kamal Adawi, M.S.,
MBA Chief Financial Officer and Treasurer
$99,000 $115,500 $714,800

CEO Pay Ratio

8:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $2,248,568
Avg Employee Cost (SGA/emp): $288,950
Employees: 161

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
161
-11.1% YoY
Revenue / Employee
$41,280
Rev: $6,646,000
Profit / Employee
$-846,677
NI: $-136,315,000
SGA / Employee
$288,950
Avg labor cost proxy
R&D / Employee
$669,745
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -67.4% -62.5% -39.9% -43.8% -47.7% -55.3% -48.5% -40.4% -36.4% -29.8% -37.8% -44.6% -41.2% -41.8% -54.2% -51.2% -49.9% -45.4% -51.8% -49.4% -49.40%
ROA -45.9% -42.5% -27.5% -30.2% -32.9% -38.1% -34.6% -28.9% -26.0% -21.3% -26.6% -31.4% -29.0% -29.4% -39.3% -37.1% -36.2% -33.0% -35.9% -34.2% -34.20%
ROIC 106.3% 121.9% -96.4% -1.1% -1.3% -1.4% -1.6% -1.3% -1.2% -1.0% -96.0% -1.1% -98.5% -99.1% -1.3% -1.3% -1.2% -1.1% -1.4% -1.4% -1.35%
ROCE -29.4% -33.7% -25.8% -29.2% -33.5% -37.3% -52.1% -44.4% -40.9% -35.0% -40.8% -45.6% -41.9% -42.1% -48.6% -46.2% -43.4% -38.4% -50.3% -47.4% -47.39%
Gross Margin -2.6% -2.7% -3.1% -2.9% -3.4% -4.3% -96.6% -11.3% -42.8% -1.4% -1.9% -1.5% 30.3% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% -1.2% -1.25%
Operating Margin -3.5% -3.8% -4.1% -4.0% -4.5% -5.8% -1.5% -48.5% -67.1% -26.4% -28.7% -26.5% -6.7% -17.0% -33.2% -25.3% -19.4% -20.0% -25.4% -25.4% -25.40%
Net Margin -4.1% -3.0% -4.0% -3.6% -4.1% -5.6% -1.3% -32.0% -56.5% -23.2% -26.3% -24.9% -5.7% -15.5% -28.0% -23.1% -17.9% -18.5% -23.6% -24.0% -24.03%
EBITDA Margin -3.4% -3.7% -3.9% -3.9% -4.3% -5.6% -1.3% -41.4% -62.3% -23.9% -25.8% -24.0% -6.0% -15.5% -22.7% -23.3% -16.1% -16.7% -23.1% -23.2% -23.16%
FCF Margin -2.7% -2.7% -3.8% -4.1% -4.0% -4.2% -2.9% -1.8% -1.7% -1.7% -2.2% -21.6% -11.5% -9.9% -9.1% -9.4% -14.0% -16.2% -16.9% -17.1% -17.11%
OCF Margin -2.3% -2.1% -2.9% -3.2% -3.2% -3.5% -2.6% -1.6% -1.6% -1.6% -2.1% -21.1% -11.4% -9.8% -9.0% -9.2% -13.6% -15.5% -16.0% -16.3% -16.32%
ROE 3Y Avg snapshot only -56.49%
ROE 5Y Avg snapshot only -50.46%
ROA 3Y Avg snapshot only -39.39%
ROIC 3Y Avg snapshot only -87.33%
ROIC Economic snapshot only -38.66%
Cash ROA snapshot only -32.33%
Cash ROIC snapshot only -1.27%
CROIC snapshot only -1.33%
NOPAT Margin snapshot only -17.44%
Pretax Margin snapshot only -20.57%
R&D / Revenue snapshot only 15.91%
SGA / Revenue snapshot only 6.70%
SBC / Revenue snapshot only 2.52%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -38.61 -28.76 -26.42 -16.05 -9.44 -7.40 -3.48 -2.38 -2.21 -1.21 -2.29 -3.90 -2.19 -2.31 -1.04 -0.53 -0.77 -0.96 -0.86 -1.11 -2.079
P/S Ratio 170.53 103.43 100.35 59.18 35.11 31.51 10.19 4.08 3.93 1.97 5.81 114.56 31.28 30.65 14.26 7.01 15.67 21.01 17.56 22.81 41.523
P/B Ratio 21.29 14.71 8.26 5.50 3.53 3.20 2.03 1.15 0.97 0.43 1.00 2.01 1.05 1.12 0.61 0.29 0.42 0.47 0.56 0.70 1.503
P/FCF -62.29 -38.25 -26.24 -14.52 -8.72 -7.49 -3.46 -2.32 -2.25 -1.14 -2.66 -5.31 -2.72 -3.11 -1.57 -0.75 -1.12 -1.30 -1.04 -1.33 -1.333
P/OCF
EV/EBITDA -50.62 -29.85 -24.17 -13.61 -6.96 -5.54 -2.22 -0.94 -0.63 0.63 -0.91 -2.73 -0.98 -1.13 -0.00 0.60 0.38 0.31 0.07 -0.15 -0.150
EV/Revenue 162.49 96.37 91.38 51.24 27.77 24.24 6.79 1.70 1.19 -1.11 2.47 81.89 14.10 14.91 0.04 -7.52 -7.21 -6.15 -1.37 2.89 2.886
EV/EBIT -49.41 -29.11 -23.52 -13.19 -6.73 -5.34 -2.12 -0.88 -0.58 0.57 -0.83 -2.49 -0.89 -1.02 -0.00 0.54 0.35 0.28 0.06 -0.14 -0.136
EV/FCF -59.36 -35.64 -23.90 -12.57 -6.90 -5.76 -2.30 -0.96 -0.68 0.64 -1.14 -3.79 -1.23 -1.51 -0.00 0.80 0.51 0.38 0.08 -0.17 -0.169
Earnings Yield -2.6% -3.5% -3.8% -6.2% -10.6% -13.5% -28.7% -42.0% -45.2% -82.9% -43.6% -25.6% -45.6% -43.2% -95.8% -1.9% -1.3% -1.0% -1.2% -90.2% -90.19%
FCF Yield -1.6% -2.6% -3.8% -6.9% -11.5% -13.4% -28.9% -43.1% -44.5% -87.9% -37.5% -18.8% -36.7% -32.2% -63.6% -1.3% -89.5% -77.0% -96.0% -75.0% -75.05%
Price/Tangible Book snapshot only 0.695
EV/Gross Profit snapshot only 5.365
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 5.78 5.78 7.79 7.79 7.79 7.79 4.40 4.40 4.40 4.40 8.48 8.48 8.48 8.48 7.58 7.58 7.58 7.58 5.79 5.79 5.786
Quick Ratio 5.78 5.78 7.79 7.79 7.79 7.79 4.40 4.40 4.40 4.40 8.48 8.48 8.48 8.48 7.58 7.58 7.58 7.58 5.79 5.79 5.786
Debt/Equity 0.25 0.25 0.17 0.17 0.17 0.17 0.23 0.23 0.23 0.23 0.28 0.28 0.28 0.28 0.27 0.27 0.27 0.27 0.38 0.38 0.376
Net Debt/Equity -1.00 -1.00 -0.74 -0.74 -0.74 -0.74 -0.68 -0.68 -0.68 -0.68 -0.57 -0.57 -0.57 -0.57 -0.61 -0.61 -0.61 -0.61 -0.61 -0.61 -0.607
Debt/Assets 0.16 0.16 0.12 0.12 0.12 0.12 0.15 0.15 0.15 0.15 0.20 0.20 0.20 0.20 0.19 0.19 0.19 0.19 0.24 0.24 0.244
Debt/EBITDA -0.63 -0.55 -0.54 -0.48 -0.42 -0.38 -0.37 -0.44 -0.49 -0.58 -0.60 -0.53 -0.59 -0.58 -0.48 -0.51 -0.54 -0.61 -0.60 -0.64 -0.640
Net Debt/EBITDA 2.50 2.18 2.37 2.11 1.84 1.66 1.11 1.32 1.45 1.73 1.23 1.09 1.20 1.19 1.10 1.15 1.22 1.38 0.97 1.03 1.035
Interest Coverage
Equity Multiplier 1.62 1.62 1.36 1.36 1.36 1.36 1.46 1.46 1.46 1.46 1.37 1.37 1.37 1.37 1.38 1.38 1.38 1.38 1.54 1.54 1.539
Cash Ratio snapshot only 5.646
Cash to Debt snapshot only 2.616
FCF to Debt snapshot only -1.388
Defensive Interval snapshot only 522.8 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.10 0.12 0.07 0.08 0.09 0.09 0.12 0.17 0.15 0.13 0.10 0.01 0.02 0.02 0.03 0.03 0.02 0.02 0.02 0.02 0.017
Inventory Turnover
Receivables Turnover 17.41 19.83 7.87 8.90 9.62 9.73 4.08 5.80 5.06 4.50 3.15 0.32 0.61 0.67 5.08 4.97 3.16 2.66 2.98 2.84 2.835
Payables Turnover 26.86 30.56 28.94 32.60 37.07 40.65 37.98 37.20 32.41 23.52 17.89 8.52 2.95 2.22 1.36 0.67 0.00 0.00 0.00 0.49 0.485
DSO 21 18 46 41 38 38 89 63 72 81 116 1136 597 547 72 73 116 137 122 129 128.7 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 14 12 13 11 10 9 10 10 11 16 20 43 124 164 269 544 752 751.8 days
Cash Conversion Cycle 7 6 34 30 28 29 80 53 61 66 95 1093 474 383 -198 -471 -623 -623.1 days
Fixed Asset Turnover snapshot only 0.064
Cash Velocity snapshot only 0.031
Capital Intensity snapshot only 50.497
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 2.6% 2.0% 77.7% 57.6% 42.2% 26.2% 72.4% 1.2% 74.7% 53.9% -34.0% -95.3% -89.7% -87.3% -78.5% 1.1% -31.2% -46.9% -51.2% -52.6% -52.64%
Net Income -82.0% -32.3% -22.4% -25.8% -19.7% -49.5% -32.8% -0.9% 16.6% 41.1% 42.9% 19.1% 16.9% -2.9% -15.7% 7.5% 2.4% 12.4% 26.8% 26.1% 26.14%
EPS -53.0% -20.5% -11.6% -22.0% -16.7% -47.0% -30.8% 0.8% 18.1% 42.0% 43.7% 21.5% 30.4% 13.9% 3.1% 21.0% 3.3% 13.3% 27.4% 27.2% 27.16%
FCF -2.4% -2.0% -3.8% -4.4% -1.1% -96.4% -32.9% 6.2% 24.1% 36.7% 51.2% 42.0% 32.2% 27.8% 10.7% 10.5% 16.0% 12.9% 9.4% 13.6% 13.65%
EBITDA -34.6% -47.6% -68.9% -74.1% -76.6% -71.2% -39.5% -4.1% 17.2% 37.6% 41.5% 21.5% 21.7% 5.9% -2.5% 13.3% 10.0% 21.2% 26.7% 27.8% 27.76%
Op. Income -32.2% -46.3% -69.4% -75.4% -78.4% -73.1% -42.1% -7.0% 14.1% 34.0% 38.2% 18.9% 19.2% 5.0% -10.4% 5.9% 1.6% 11.1% 29.8% 30.5% 30.46%
OCF Growth snapshot only 16.41%
Asset Growth snapshot only -27.63%
Equity Growth snapshot only -35.00%
Debt Growth snapshot only -8.70%
Shares Change snapshot only 1.40%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.3% 1.4% 1.3% 1.2% 1.0% 93.4% 1.1% 1.3% 1.1% 79.6% 26.4% -45.5% -36.5% -37.3% -37.5% -40.4% -50.1% -53.1% -59.0% -64.1% -64.13%
Revenue 5Y 60.9% 65.1% 66.2% 72.7% 75.4% 75.8% 87.9% 1.0% 96.2% 91.7% 68.1% 0.4% 8.6% 7.1% 5.0% 4.8% -8.5% -17.2% -26.7% -30.9% -30.89%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 80.8% 80.8% 62.9% 62.9% 62.9% 62.9% 32.7% 32.7% 32.7% 32.7% -6.7% -6.7% -6.7% -6.7% -21.8% -21.8% -21.8% -21.8% -23.3% -23.3% -23.25%
Assets 5Y 55.7% 55.7% 57.5% 57.5% 57.5% 57.5% 46.3% 46.3% 46.3% 46.3% 18.9% 18.9% 18.9% 18.9% 7.8% 7.8% 7.8% 7.8% -12.5% -12.5% -12.52%
Equity 3Y 70.8% 70.8% 61.7% 61.7% 61.7% 61.7% 25.5% 25.5% 25.5% 25.5% -1.4% -1.4% -1.4% -1.4% -22.3% -22.3% -22.3% -22.3% -24.6% -24.6% -24.63%
Book Value 3Y 41.0% 41.4% 41.8% 41.8% 41.8% 42.9% 15.4% 15.2% 16.8% 20.3% -5.3% -4.0% -8.4% -8.1% -27.5% -27.4% -27.4% -27.4% -29.5% -29.5% -29.54%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.57 0.62 0.74 0.75 0.78 0.82 0.84 0.78 0.87 0.92 0.74 0.12 0.12 0.10 0.03 0.00 0.01 0.03 0.18 0.20 0.198
Earnings Stability 0.83 0.92 0.93 0.94 0.93 0.94 0.97 0.96 0.84 0.62 0.53 0.67 0.44 0.25 0.17 0.16 0.02 0.02 0.16 0.45 0.449
Margin Stability 0.48 0.39 0.39 0.50 0.57 0.56 0.49 0.32 0.19 0.05 0.01 0.27 0.10 0.01 0.07 0.02 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.87 0.91 0.90 0.92 0.80 0.87 1.00 0.93 0.84 0.83 0.92 0.93 0.99 0.94 0.97 0.99 0.95 0.89 0.90 0.895
Earnings Smoothness
ROE Trend -0.08 0.06 0.11 0.13 0.14 0.13 -0.20 -0.07 0.03 0.11 0.01 -0.10 -0.07 -0.09 -0.07 -0.05 -0.08 -0.07 -0.15 -0.09 -0.093
Gross Margin Trend 3.73 3.00 1.07 1.42 0.64 -0.33 0.60 1.39 1.42 2.02 1.77 -5.47 1.61 2.05 1.88 5.06 1.92 1.47 1.26 3.99 3.985
FCF Margin Trend 2.28 2.55 1.12 1.21 -1.19 -1.51 -0.33 0.87 1.63 1.73 1.21 -18.66 -8.60 -6.89 -6.51 2.28 -7.41 -10.38 -11.23 -1.63 -1.632
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.52 0.58 0.77 0.86 0.87 0.83 0.88 0.90 0.89 0.99 0.82 0.72 0.80 0.74 0.66 0.70 0.67 0.71 0.78 0.79 0.794
FCF/OCF 1.19 1.31 1.31 1.28 1.24 1.19 1.14 1.14 1.11 1.07 1.05 1.02 1.01 1.01 1.01 1.01 1.03 1.04 1.06 1.05 1.048
FCF/Net Income snapshot only 0.832
CapEx/Revenue 43.4% 63.3% 90.8% 90.0% 78.1% 68.5% 36.9% 21.0% 17.4% 11.9% 9.7% 46.8% 7.2% 6.0% 5.4% 13.8% 37.2% 68.1% 89.6% 79.1% 79.10%
CapEx/Depreciation snapshot only 0.400
Accruals Ratio -0.22 -0.18 -0.06 -0.04 -0.04 -0.07 -0.04 -0.03 -0.03 -0.00 -0.05 -0.09 -0.06 -0.08 -0.13 -0.11 -0.12 -0.10 -0.08 -0.07 -0.071
Sloan Accruals snapshot only -0.245
Cash Flow Adequacy snapshot only -20.636
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -5.3% -7.3% -7.3% -0.5% -0.7% -0.2% -0.6% -0.6% -0.7% -0.9% -0.0% -10.1% -19.3% -18.0% -38.3% -0.7% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return -5.3% -7.3% -7.3% -0.5% -0.7% -0.2% -0.6% -0.6% -0.7% -0.9% -0.0% -10.1% -19.3% -18.0% -38.3% -0.7% 0.0% 0.0% 0.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.34 1.09 0.98 0.95 0.90 0.94 0.91 0.89 0.87 0.84 0.84 0.89 0.90 0.91 0.95 0.95 0.98 1.01 0.96 0.97 0.969
EBIT Margin -3.29 -3.31 -3.89 -3.89 -4.13 -4.54 -3.20 -1.92 -2.03 -1.95 -3.00 -32.88 -15.87 -14.62 -14.35 -13.93 -20.63 -21.66 -21.41 -21.22 -21.222
Asset Turnover 0.10 0.12 0.07 0.08 0.09 0.09 0.12 0.17 0.15 0.13 0.10 0.01 0.02 0.02 0.03 0.03 0.02 0.02 0.02 0.02 0.017
Equity Multiplier 1.47 1.47 1.45 1.45 1.45 1.45 1.40 1.40 1.40 1.40 1.42 1.42 1.42 1.42 1.38 1.38 1.38 1.38 1.44 1.44 1.444
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-2.25 $-2.06 $-2.21 $-2.42 $-2.62 $-3.03 $-2.90 $-2.40 $-2.15 $-1.76 $-1.63 $-1.88 $-1.50 $-1.51 $-1.58 $-1.49 $-1.45 $-1.31 $-1.15 $-1.08 $-1.08
Book Value/Share $4.08 $4.03 $7.09 $7.05 $7.02 $7.00 $4.98 $4.94 $4.92 $4.91 $3.74 $3.64 $3.14 $3.13 $2.71 $2.69 $2.69 $2.68 $1.74 $1.73 $1.50
Tangible Book/Share $4.08 $4.03 $7.09 $7.05 $7.02 $7.00 $4.98 $4.94 $4.92 $4.91 $3.74 $3.64 $3.14 $3.13 $2.71 $2.69 $2.69 $2.68 $1.74 $1.73 $1.73
Revenue/Share $0.51 $0.57 $0.58 $0.66 $0.71 $0.71 $0.99 $1.40 $1.21 $1.08 $0.64 $0.06 $0.10 $0.11 $0.12 $0.11 $0.07 $0.06 $0.06 $0.05 $0.05
FCF/Share $-1.39 $-1.55 $-2.23 $-2.67 $-2.84 $-2.99 $-2.92 $-2.46 $-2.12 $-1.86 $-1.40 $-1.38 $-1.20 $-1.13 $-1.05 $-1.06 $-1.00 $-0.97 $-0.94 $-0.90 $-0.90
OCF/Share $-1.17 $-1.19 $-1.70 $-2.08 $-2.29 $-2.51 $-2.55 $-2.17 $-1.91 $-1.73 $-1.34 $-1.35 $-1.20 $-1.12 $-1.04 $-1.04 $-0.98 $-0.93 $-0.89 $-0.86 $-0.86
Cash/Share $5.12 $5.06 $6.43 $6.39 $6.37 $6.35 $4.49 $4.45 $4.43 $4.43 $3.20 $3.12 $2.68 $2.68 $2.37 $2.36 $2.35 $2.35 $1.71 $1.70 $1.46
EBITDA/Share $-1.63 $-1.85 $-2.20 $-2.47 $-2.81 $-3.11 $-3.03 $-2.52 $-2.29 $-1.91 $-1.75 $-1.92 $-1.50 $-1.51 $-1.50 $-1.42 $-1.34 $-1.18 $-1.09 $-1.01 $-1.01
Debt/Share $1.03 $1.02 $1.20 $1.19 $1.19 $1.18 $1.12 $1.12 $1.11 $1.11 $1.05 $1.02 $0.88 $0.88 $0.72 $0.72 $0.72 $0.72 $0.66 $0.65 $0.65
Net Debt/Share $-4.09 $-4.04 $-5.23 $-5.20 $-5.18 $-5.16 $-3.36 $-3.33 $-3.32 $-3.32 $-2.15 $-2.09 $-1.80 $-1.80 $-1.65 $-1.64 $-1.64 $-1.63 $-1.06 $-1.05 $-1.05
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -6.679
Altman Z-Prime snapshot only -13.603
Piotroski F-Score 4 5 5 5 5 4 3 3 3 4 3 3 4 3 2 4 2 2 2 2 2
Beneish M-Score -1.75 -2.39 -1.71 -1.19 -1.44 -1.59 0.69 13.01 72.67 27.39 -7.71 -9.21 -73.61 -4.99 -3.23 -2.64 1.73 -0.47 -4.10 -4.96 -4.962
Ohlson O-Score snapshot only -5.077
ROIC (Greenblatt) snapshot only -49.43%
Net-Net WC snapshot only $0.81
EVA snapshot only $-118282560.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB
Credit Score 73.01 72.75 74.12 74.77 75.45 72.97 43.44 43.41 43.09 43.22 43.56 43.40 43.18 43.44 43.06 43.07 42.94 42.82 42.67 42.28 42.276
Credit Grade snapshot only 12
Credit Trend snapshot only -0.795
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 36
Sector Credit Rank snapshot only 34

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms